About Servier
Servier is a company based in Suresnes (France) founded in 1954. The company has 3 employees as of March 31, 2024. Servier has completed 3 acquisitions, including Day One, Groupe REALITES and Servier Symphogen. Servier offers products and services including Cancer Treatments, Cardio-metabolism Products, and Neurology Treatments.
- Headquarter Suresnes, France
- Employees 3 as on 31 Mar, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Servier Danmark A/S
-
Annual Revenue
$4.6 M (USD)27as on Sep 30, 2022
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$912.74 K (USD), Grant
Feb 03, 2022
- Investors
-
Employee Count
3
as on Mar 31, 2024
-
Investments & Acquisitions
Day One
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Servier
Servier offers a comprehensive portfolio of products and services, including Cancer Treatments, Cardio-metabolism Products, and Neurology Treatments.
Medications targeting cancers through innovative research
Solutions for heart and metabolic conditions
Drugs for neurological disorders and patient care
People of Servier
Unlock access to complete
Funding Insights of Servier
Investors in Servier
Servier has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Ministry of Economy, Finance and Industrial and Digital Sovereignty.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked |
Investor details for Servier
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Servier
Servier has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Day One, Groupe REALITES and Servier Symphogen.
Investment portfolio details for Servier
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Investigational cancer drugs, including pan-RAF inhibitors, are developed.
|
Locked | Locked | 2018 | Locked | |
|
Real estate development and management are conducted in France.
|
Locked | Locked | 2003 | Locked | |
|
Servier Symphogen is focused on developing antibody therapeutics for cancer.
|
Locked | Locked | 2000 | Locked |
Complete acquisition details for Servier
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Servier
Detailed financials for Servier
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Servier Comparisons
Peer comparison for Servier
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Servier
Detailed competitors of Servier
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Servier
Complete news archive for Servier
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Servier
Servier was founded in 1954 and raised its 1st funding round 65 years after it was founded.
Servier is headquartered in Suresnes, France. It is registered at Suresnes, Ile-de-france, France.
As of Mar 31, 2024, the latest employee count at Servier is 3.
Annual revenue of Servier is $4.6M as on Sep 30, 2022.
Servier was established in 1954 in Suresnes, France, within the pharmaceuticals sector. Therapies are developed for cancers, cardio-metabolic conditions, and neurological disorders, with emphasis on precision medicine and targeted treatments. Generic drugs are provided alongside these innovations. Operations encompass the full drug lifecycle, from research and development to access and surveillance, while patient requirements are addressed throughout. Collaborations in research and development are pursued actively.
Servier offers Cancer Treatments, Cardio-metabolism Products, and Neurology Treatments.
Servier has made 3 acquisitions, including Day One, Groupe REALITES, and Servier Symphogen.
Servier has 1 investor. Key investors include Ministry of Economy, Finance and Industrial and Digital Sovereignty.